EU_Haem_contents.qxp 17/2/09 15:15 Page 3
Contents
Advisory Panel
5
Foreword
6
Luigi D Notarangelo
Chair, Paediatric Immunology Research, and Professor of Paediatrics and Pathology, Harvard Medical School
Editor’s Choice
7
Snake Venom and Haemostasis – An Overview
Ponlapat Rojnuckarin
Head, Division of Haematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
Coagulation Disorders
Awareness of Mild Bleeding Disorders 12
Pieter W Kamphuisen
Department of Vascular Medicine, Academic Medical Centre, Amsterdam
Haemophilia
Inhibitors in Haemophilia A – Ongoing Research and Clinical Practice 14
Wolfhart Kreuz,
1
Carmen Escuriola-Ettingshausen
1
and Günter Auerswald
2
1. Centre of Paediatrics III, Department of Haematology, Oncology and Haemostaseology, Johann-Wolfgang-Goethe
University Hospital, Frankfurt; 2. Prof.–Hess Children’s Hospital, Klinikum Bremen-Mitte, Bremen
Haemophilia Treatment – Current and Future Challenges 21
J Blatny˘,
1
J Ingerslev,
2
A Huth-Kühne,
3
T Lambert
4
and J Windyga
5
1. Children’s University Hospital, Brno; 2. Aarhus University; 3. Kurpfalzkrankenhaus Hemophilia Centre,
Heidelberg; 4. Assistance Publique, Hôpitaux de Paris; 5. Institute of Transfusion Medicine, Warsaw
Immunological Aspects of Inhibitor Development in Haemophilia 28
David Keeling
1
and Cindy Lee
2
1. Consultant Haematologist, Oxford Radcliffe Hospitals, and Honorary Senior Clinical Lecturer
in Haematology, University of Oxford; 2. Staff Medical Writer, Touch Briefings
von Willebrand Disease
Long-term Prophylaxis in von Willebrand Disease –
How Should It Be Given and for Whom? 34
Erik Berntorp, Sharyne M Donfield and Thomas C Abshire
The von Willebrand Disease Prophylaxis (VIP) Study Group
Current Management of von Willebrand Disease 38
Augusto B Federici
Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Department of Medicine and
Medical Specialities, IRCCS Maggiore Policlinico Hospital, Mangiagalli
Platelet Disorders
Congenital Disorders of Platelet Function 43
Gian Marco Podda, Mariateresa Pugliano and Marco Cattaneo
San Paolo Hospital, Department of Medicine, Surgery and Dentistry, University of Milan
Romiplostim – A Thrombopoiesis-stimulating Peptibody for the
Management of Chronic Immune Thrombocytopenic Purpura in Adults 48
Adrian Newland
Professor of Haematology, Barts and the London NHS Trust
Thrombosis
Management Based on Residual Vein Thrombosis to Optimise the
Duration of Oral Anticoagulants After Deep Vein Thrombosis 52
Sergio Siragusa
Haematology Department, University Hospital of Palermo
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant
Changes Synergistically Increase the Risk of Venous Thrombosis 55
Mirjam E Meltzer,
1,2
Frits R Rosendaal
2
and Ton Lisman
1,3
1. Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht;
2. Department of Clinical Epidemiology, Leiden University Medical Centre; 3. Surgical Research Laboratory,
Department of Surgery, University Medical Centre Groningen, University of Groningen
EUROPEAN HAEMATOLOGY 3
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100